Publication
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
Robert G. Hart, Mukul Sharma, Hardi Mundl, Scott E. Kasner, Shrikant I. Bangdiwala, Scott D. Berkowitz, Balakumar Swaminathan, Pablo Lavados, Yongjun Wang, Yilong Wang, Antonio Davalos, Nikolay Shamalov, Robert Mikulik, Luis Cunha, Arne Lindgren, Antonio Arauz, Wilfried Lang, Anna Czlonkowska, Jens Eckstein, Rubens J. Gagliardi, Pierre Amarenco, Sebastian F. Ameriso, Turgut Tatlisumak, Roland Veltkamp, Graeme J. Hankey, Danilo Toni, Daniel Bereczki, Shinichiro Uchiyama, George Ntaios, Byung-Woo Yoon, Raf Brouns, Matthias Endres, Keith W. Muir, Natan Bornstein, Serefnur Ozturk, Martin J. O’Donnell, Matthys M. De Vries Basson, Guillaume Pare, Calin Pater, Bodo Kirsch, Patrick Sheridan, Gary Peters, Jeffrey I. Weitz, W. Frank Peacock, Ashkan Shoamanesh, Oscar R. Benavente, Campbell Joyner, Ellison Themeles, Stuart J. Connolly
New England Journal of Medicine, June 2018, New England Journal of Medicine (NEJM/MMS)
DOI: 10.1056/nejmoa1802686